Option Care Health (OPCH) Financials

$32.26 +0.52 (+1.64%)

Closing price 04:00 PM Eastern

Extended Trading

$31.50 -0.76 (-2.36%)

As of 04:28 PM Eastern

Annual Income Statements for Option Care Health

This table shows Option Care Health's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	208	261	172	140	-8.08	-76	-6.12	3.88	-52	-310
Consolidated Net Income / (Loss)	212	267	151	140	-8.08	-76	-6.12	3.88	-43	-300
Net Income / (Loss) Continuing Operations	212	267	151	140	-8.08	-76	-6.12	3.88	-36	-305
Total Pre-Tax Income	284	359	206	116	-5.24	-78	-8.77	-15	-34	-326
Total Operating Income	322	315	240	191	111	-0.32	38	27	-11	-247
Total Gross Profit	1,013	981	867	780	682	513	422	446	262	260
Total Revenue	4,998	4,302	3,945	3,439	3,033	2,310	1,940	1,828	936	982
Operating Revenue	4,998	4,302	3,945	3,439	3,033	2,310	1,940	1,828	936	982
Total Cost of Revenue	3,985	3,321	3,078	2,659	2,350	1,797	1,518	1,382	700	722
Operating Cost of Revenue	3,985	3,321	3,078	2,659	2,350	1,797	1,518	1,382	674	722
Total Operating Expenses	691	667	627	589	572	513	384	419	246	507
Selling, General & Admin Expense	630	607	566	526	500	460	346	338	209	208
Depreciation Expense	61	59	61	63	71	54	38	35	22	23
Total Other Income / (Expense), net	-38	44	-34	-74	-116	-78	-47	-42	-23	-79
Interest Expense	49	51	54	67	108	74	46	-	0.00	79
Interest & Investment Income	5.96	5.53	5.13	6.03	3.31	2.84	1.02	2.19	-38	-
Other Income / (Expense), net	4.83	90	14	-13	-12	-6.99	-2.23	-44	14	0.00
Income Tax Expense	72	92	55	-23	2.83	-2.27	-2.65	-19	2.02	-22
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	3.93	6.18	-22	-	-	-	-	-	-	-
Basic Earnings per Share	$1.23	$1.49	$0.83	$0.78	($0.04)	($0.49)	($0.04)	$0.03	($0.55)	($4.51)
Weighted Average Basic Shares Outstanding	171.57M	178.97M	181.11M	179.86M	180.97M	156.28M	142.61M	142.61M	93.74M	68.71M
Diluted Earnings per Share	$1.23	$1.48	$0.83	$0.77	($0.04)	($0.49)	($0.04)	$0.03	($0.55)	($4.51)
Weighted Average Diluted Shares Outstanding	172.85M	180.38M	182.08M	181.21M	180.97M	156.28M	142.61M	142.61M	93.74M	68.71M
Weighted Average Basic & Diluted Shares Outstanding	165.32M	173.50M	181.96M	179.94M	179.81M	156.28M	142.61M	142.61M	93.74M	68.71M

This table shows Option Care Health's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	44	62	48	53	45	51	56	114	39	55	48
Consolidated Net Income / (Loss)	47	60	54	53	45	57	56	114	39	48	39
Net Income / (Loss) Continuing Operations	47	60	54	53	45	57	56	114	39	48	39
Total Pre-Tax Income	64	81	74	72	57	79	70	156	54	65	52
Total Operating Income	79	87	85	81	69	85	81	82	67	68	61
Total Gross Profit	263	268	257	249	239	247	254	251	229	231	218
Total Revenue	1,333	1,346	1,279	1,227	1,146	1,124	1,093	1,069	1,016	1,027	1,021
Operating Revenue	1,333	1,346	1,279	1,227	1,146	1,124	1,093	1,069	1,016	1,027	1,021
Total Cost of Revenue	1,070	1,078	1,022	978	908	877	839	818	787	796	803
Operating Cost of Revenue	1,070	1,078	1,022	978	908	877	839	818	787	796	803
Total Operating Expenses	184	181	172	169	169	163	173	168	162	163	157
Selling, General & Admin Expense	168	165	157	154	155	148	158	154	148	148	142
Depreciation Expense	16	17	15	15	15	15	15	15	15	15	15
Total Other Income / (Expense), net	-16	-5.99	-12	-8.63	-12	-5.63	-11	73	-12	-3.41	-8.64
Interest Expense	13	11	12	13	13	12	12	13	14	15	14
Interest & Investment Income	1.73	2.04	1.39	1.41	1.13	1.42	1.27	1.40	1.44	1.06	1.47
Other Income / (Expense), net	-4.13	2.85	-0.58	2.56	0.00	5.38	-0.45	85	0.00	10	3.89
Income Tax Expense	17	21	20	19	12	22	14	41	15	17	13
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	2.40	-	6.13	-	-	-	-0.05	-	-	-	-9.26
Basic Earnings per Share	$0.28	$0.34	$0.32	$0.31	$0.26	$0.32	$0.31	$0.64	$0.22	$0.26	$0.21
Weighted Average Basic Shares Outstanding	165.46M	171.57M	170.64M	172.93M	173.93M	178.97M	178.83M	179.81M	181.26M	181.11M	181.88M
Diluted Earnings per Share	$0.28	$0.36	$0.31	$0.30	$0.26	$0.33	$0.31	$0.63	$0.21	$0.26	$0.21
Weighted Average Diluted Shares Outstanding	166.80M	172.85M	171.94M	174.09M	175.62M	180.38M	180.53M	181.24M	182.74M	182.08M	183.02M
Weighted Average Basic & Diluted Shares Outstanding	163.75M	165.32M	170.18M	171.02M	173.82M	173.50M	177.13M	179.88M	179.76M	181.96M	181.90M

This table details how cash moves in and out of Option Care Health's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	69	50	175	20	32	31	-17	8.25	-6.01	15
Net Cash From Operating Activities	323	371	268	209	127	39	24	38	-43	-64
Net Cash From Continuing Operating Activities	323	371	268	209	127	39	24	38	-36	-63
Net Income / (Loss) Continuing Operations	212	267	151	140	-8.08	-76	-6.12	3.88	-36	-305
Consolidated Net Income / (Loss)	212	267	151	140	-8.08	-76	-6.12	3.88	-43	-300
Depreciation Expense	63	62	65	69	78	58	41	38	22	23
Amortization Expense	4.63	4.45	4.30	5.00	5.52	4.54	3.11	3.00	4.04	3.44
Non-Cash Adjustments To Reconcile Net Income	34	47	6.45	17	27	25	7.79	1.46	-17	255
Changes in Operating Assets and Liabilities, net	9.82	-9.92	41	-22	25	28	-21	-8.53	-8.53	-39
Net Cash From Investing Activities	-36	-57	-108	-112	-26	-728	-37	-24	-73	13
Net Cash From Continuing Investing Activities	-36	-57	-108	-112	-26	-728	-37	-24	-73	-12
Purchase of Property, Plant & Equipment	-36	-42	-35	-26	-27	-28	-26	-25	-9.87	-12
Acquisitions	0.00	-12	-87	-86	0.00	-700	-11	0.00	-68	0.00
Sale of Property, Plant & Equipment	0.00	3.74	15	0.00	0.00	0.01	0.00	0.48	4.18	0.00
Other Investing Activities, net	-0.86	-5.89	0.00	0.00	0.54	0.63	0.00	0.00	-	0.00
Net Cash From Financing Activities	-218	-265	15	-77	-69	719	-4.15	-5.15	110	67
Net Cash From Continuing Financing Activities	-218	-265	15	-77	-69	719	-4.15	-5.15	110	67
Repayment of Debt	-3.06	-12	-6.00	-932	-187	-261	-5.15	-4.15	-78	-197
Repurchase of Common Equity	-253	-250	0.00	0.00	-	-	-	-	-	-
Issuance of Debt	50	0.00	0.00	855	0.00	981	1.00	0.00	104	204
Other Financing Activities, net	-12	-3.12	21	-0.03	-0.90	-1.19	0.00	-1.00	-0.20	-
Cash Interest Paid	72	70	50	61	98	51	47	43	35	34
Cash Income Taxes Paid	65	75	13	5.71	2.88	2.41	1.60	1.19	-0.37	0.11

This table details how cash moves in and out of Option Care Health's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-241	-70	106	157	-124	-43	-55	143	3.59	39	51
Net Cash From Operating Activities	-7.21	36	160	196	-69	51	61	170	90	43	87
Net Cash From Continuing Operating Activities	-7.21	36	160	196	-69	51	61	170	90	43	87
Net Income / (Loss) Continuing Operations	47	60	54	53	45	57	56	114	39	48	39
Consolidated Net Income / (Loss)	47	60	54	53	45	57	56	114	39	48	39
Depreciation Expense	16	17	15	15	15	16	16	16	15	16	16
Amortization Expense	1.15	1.16	1.16	1.17	1.13	1.13	1.13	1.10	1.08	1.10	1.09
Non-Cash Adjustments To Reconcile Net Income	8.12	7.24	9.53	6.61	10	23	9.47	7.60	7.32	-3.65	4.16
Changes in Operating Assets and Liabilities, net	-80	-50	81	119	-140	-46	-21	31	27	-17	27
Net Cash From Investing Activities	-127	-11	-9.67	-9.78	-5.82	-16	-14	-21	-5.76	-3.63	-34
Net Cash From Continuing Investing Activities	-127	-11	-9.67	-9.78	-5.82	-16	-14	-21	-5.76	-3.63	-34
Purchase of Property, Plant & Equipment	-9.37	-10	-9.67	-9.78	-5.82	-20	-8.43	-7.79	-5.76	-18	-7.06
Acquisitions	-117	-	-	-	-	0.36	-	-	-	-0.05	-27
Net Cash From Financing Activities	-107	-95	-45	-29	-50	-78	-101	-5.50	-80	-1.11	-1.24
Net Cash From Continuing Financing Activities	-107	-95	-45	-29	-50	-78	-101	-5.50	-80	-1.11	-1.24
Repayment of Debt	0.32	-1.63	0.48	-0.41	-1.50	-1.50	-1.50	-5.25	-3.50	-1.50	-1.50
Other Financing Activities, net	-108	-1.15	-3.05	-0.00	-8.18	-1.18	0.21	-0.25	-1.90	0.39	0.26
Cash Interest Paid	11	23	13	24	12	23	12	23	11	21	7.79
Cash Income Taxes Paid	0.83	19	13	32	0.00	22	32	22	0.00	6.75	1.72

This table presents Option Care Health's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	3,422	3,217	3,113	2,791	2,647	2,590	1,428	603	605	531
Total Current Assets	1,323	1,094	994	710	657	559	467	187	173	184
Cash & Equivalents	413	344	294	119	99	67	36	39	9.57	16
Accounts Receivable	410	378	378	338	328	324	310	86	109	97
Inventories, net	388	274	224	183	159	116	83	38	36	43
Prepaid Expenses	112	99	98	69	71	51	38	19	19	28
Plant, Property, & Equipment, net	127	121	108	112	121	133	93	27	33	32
Total Noncurrent Assets	1,972	2,002	2,010	1,603	1,869	1,898	868	390	399	315
Goodwill	1,540	1,540	1,533	1,478	1,429	1,426	632	367	366	309
Intangible Assets	301	20	22	-	23	386	220	19	31	5.13
Other Noncurrent Operating Assets	130	442	454	99	417	86	15	2.12	1.99	1.16
Total Liabilities & Shareholders' Equity	3,422	3,217	3,113	2,791	2,647	2,590	1,428	603	605	531
Total Liabilities	2,018	1,795	1,727	1,615	1,632	1,683	825	606	567	549
Total Current Liabilities	780	618	565	460	434	330	240	105	130	153
Short-Term Debt	6.51	6.00	6.00	6.00	9.25	9.25	4.15	1.72	19	24
Accounts Payable	611	427	379	279	283	221	188	66	64	65
Accrued Expenses	78	75	84	72	64	34	23	26	37	53
Current Employee Benefit Liabilities	63	93	77	84	59	46	25	-	-	-
Other Current Liabilities	22	18	19	19	19	20	0.00	4.62	3.68	3.49
Total Noncurrent Liabilities	1,237	1,177	1,161	1,155	1,198	1,353	585	501	436	396
Long-Term Debt	1,105	1,057	1,058	1,060	1,115	1,277	535	479	433	394
Noncurrent Deferred & Payable Income Tax Liabilities	48	35	22	0.00	3.34	2.14	33	-	2.28	0.24
Other Noncurrent Operating Liabilities	85	85	81	95	79	73	17	22	0.76	1.86
Total Equity & Noncontrolling Interests	1,404	1,422	1,386	1,176	1,016	907	603	-85	-34	-81
Total Preferred & Common Equity	1,404	1,422	1,386	1,176	1,016	907	603	-85	-34	-81
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,404	1,422	1,386	1,176	1,016	907	603	-85	-34	-81
Common Stock	1,231	1,204	1,177	1,139	1,129	1,008	620	625	612	532
Retained Earnings	669	458	190	40	-100	-92	-16	-710	-645	-602
Treasury Stock	-508	-255	-2.40	-2.40	-2.40	-2.40	0.00	-0.02	0.00	-11
Accumulated Other Comprehensive Income / (Loss)	11	15	21	-0.45	-11	-7.20	0.84	-	-	-

This table presents Option Care Health's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	3,309	3,428	3,349	3,250	3,244	3,321	3,130	3,073
Total Current Assets	1,099	1,321	1,227	1,130	1,116	1,198	1,030	952
Cash & Equivalents	171	483	377	220	386	441	298	255
Accounts Receivable	477	429	468	574	383	397	395	364
Inventories, net	369	311	281	242	251	263	250	236
Prepaid Expenses	82	99	101	95	95	98	87	96
Plant, Property, & Equipment, net	131	126	124	121	108	107	106	96
Total Noncurrent Assets	2,078	1,980	1,997	1,999	2,019	2,016	1,640	2,025
Goodwill	1,606	1,540	1,540	1,540	1,540	1,541	1,534	1,533
Intangible Assets	337	310	318	327	344	22	-	23
Other Noncurrent Operating Assets	135	131	139	132	135	454	106	469
Total Liabilities & Shareholders' Equity	3,309	3,428	3,349	3,250	3,244	3,321	3,130	3,073
Total Liabilities	1,958	2,001	1,937	1,820	1,804	1,846	1,780	1,736
Total Current Liabilities	714	763	695	637	624	668	619	587
Short-Term Debt	6.51	6.51	6.51	6.00	6.00	6.00	6.00	6.00
Accounts Payable	529	592	536	486	430	468	449	410
Accrued Expenses	106	82	69	83	89	103	96	94
Current Employee Benefit Liabilities	50	61	62	43	81	73	49	58
Other Current Liabilities	22	22	22	19	18	19	19	19
Total Noncurrent Liabilities	1,244	1,238	1,242	1,183	1,179	1,177	1,162	1,149
Long-Term Debt	1,104	1,105	1,106	1,056	1,057	1,057	1,058	1,059
Noncurrent Deferred & Payable Income Tax Liabilities	49	45	45	38	34	35	31	11
Other Noncurrent Operating Liabilities	91	88	92	89	89	84	73	80
Total Equity & Noncontrolling Interests	1,351	1,426	1,411	1,429	1,440	1,475	1,350	1,337
Total Preferred & Common Equity	1,351	1,426	1,411	1,429	1,440	1,475	1,350	1,337
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,351	1,426	1,411	1,429	1,440	1,475	1,350	1,337
Common Stock	1,235	1,224	1,215	1,206	1,198	1,188	1,181	1,172
Retained Earnings	716	609	555	502	400	344	230	143
Treasury Stock	-609	-417	-374	-295	-179	-78	-78	-2.40
Accumulated Other Comprehensive Income / (Loss)	8.65	9.50	16	17	21	21	18	25

This table displays calculated financial ratios and metrics derived from Option Care Health's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	16.17%	9.07%	14.72%	13.39%	31.26%	19.11%	6.11%	95.39%	-4.75%	6.46%
EBITDA Growth	-16.20%	45.32%	29.02%	37.59%	231.43%	-31.29%	231.88%	-18.03%	113.36%	-212.06%
EBIT Growth	-19.23%	58.96%	43.38%	78.87%	1,457.24%	-120.29%	313.32%	-594.67%	101.38%	-152.50%
NOPAT Growth	2.63%	33.25%	-23.30%	195.61%	34,819.44%	-100.83%	40.29%	348.24%	95.55%	-152.50%
Net Income Growth	-20.69%	77.40%	7.62%	1,832.27%	89.36%	-1,141.54%	-257.68%	109.07%	85.75%	-103.52%
EPS Growth	-16.89%	78.31%	7.79%	2,025.00%	91.84%	-1,141.54%	-257.68%	109.07%	87.80%	-109.77%
Operating Cash Flow Growth	-12.90%	38.78%	28.28%	63.72%	222.78%	61.56%	-35.50%	189.02%	33.77%	-104.45%
Free Cash Flow Firm Growth	11.27%	211.55%	-143.61%	215.15%	115.97%	-59.78%	-1,063.04%	163.99%	-283.21%	74.01%
Invested Capital Growth	-1.76%	-0.73%	22.76%	-13.94%	-4.02%	92.28%	151.20%	-9.69%	24.51%	-36.95%
Revenue Q/Q Growth	4.65%	2.31%	2.60%	3.69%	2.85%	-14.15%	-4.53%	108.98%	-0.39%	4.13%
EBITDA Q/Q Growth	0.43%	2.51%	6.01%	7.08%	16.60%	-17.99%	-14.11%	31.20%	-47.31%	28.10%
EBIT Q/Q Growth	-0.02%	2.90%	7.95%	11.75%	37.68%	-153.34%	-20.89%	4.29%	-90.00%	26.03%
NOPAT Q/Q Growth	1.44%	5.13%	-20.50%	40.45%	37.78%	-102.51%	-70.47%	254.55%	-132.19%	26.03%
Net Income Q/Q Growth	1.42%	3.75%	-15.65%	70.05%	80.65%	-90.47%	-115.38%	105.11%	10.72%	12.98%
EPS Q/Q Growth	2.50%	4.96%	-21.70%	-48.32%	96.75%	-90.47%	-115.38%	105.11%	24.66%	12.26%
Operating Cash Flow Q/Q Growth	-4.39%	2.07%	-7.55%	23.47%	2.22%	37.04%	-58.94%	382.09%	-17.70%	3.12%
Free Cash Flow Firm Q/Q Growth	-6.94%	-1.11%	-322.14%	216.10%	-1.83%	39.42%	-776.33%	183.35%	-111.61%	23.56%
Invested Capital Q/Q Growth	2.34%	1.13%	0.45%	-13.32%	0.75%	-0.42%	150.46%	-1.13%	1.34%	-4.08%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	20.27%	22.81%	21.98%	22.67%	22.50%	22.20%	21.77%	24.40%	28.01%	26.47%
EBITDA Margin	7.90%	10.95%	8.22%	7.31%	6.02%	2.39%	4.13%	1.32%	3.15%	-22.47%
Operating Margin	6.44%	7.31%	6.09%	5.55%	3.65%	-0.01%	1.97%	1.49%	-1.17%	-25.14%
EBIT Margin	6.54%	9.40%	6.45%	5.16%	3.27%	-0.32%	1.86%	-0.92%	0.37%	-25.14%
Profit (Net Income) Margin	4.24%	6.21%	3.82%	4.07%	-0.27%	-3.29%	-0.32%	0.21%	-4.57%	-30.56%
Tax Burden Percent	74.69%	74.45%	73.17%	120.09%	154.03%	97.09%	69.74%	-26.37%	125.20%	91.96%
Interest Burden Percent	86.82%	88.70%	80.87%	65.64%	-5.28%	1,069.69%	-24.33%	87.06%	-1,000.21%	132.14%
Effective Tax Rate	25.31%	25.55%	26.83%	-20.09%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	11.33%	10.90%	8.99%	12.07%	3.72%	-0.01%	3.47%	4.12%	-1.75%	-34.15%
ROIC Less NNEP Spread (ROIC-NNEP)	7.30%	15.32%	5.25%	0.95%	-3.91%	-8.80%	-3.49%	0.70%	-9.92%	-65.43%
Return on Net Nonoperating Assets (RNNOA)	3.66%	8.12%	2.77%	0.70%	-4.56%	-10.04%	-5.50%	17.60%	-417.08%	-267.72%
Return on Equity (ROE)	14.99%	19.03%	11.75%	12.77%	-0.84%	-10.06%	-2.04%	21.72%	-418.83%	-301.87%
Cash Return on Invested Capital (CROIC)	13.10%	11.63%	-11.45%	27.05%	7.82%	-63.16%	-82.64%	14.30%	-23.59%	11.18%
Operating Return on Assets (OROA)	9.84%	12.78%	8.62%	6.53%	3.79%	-0.36%	3.55%	-2.80%	0.60%	-36.44%
Return on Assets (ROA)	6.38%	8.44%	5.10%	5.14%	-0.31%	-3.78%	-0.60%	0.64%	-7.53%	-44.29%
Return on Common Equity (ROCE)	14.99%	19.03%	11.75%	12.77%	-0.84%	-10.06%	-1.76%	-72.00%	2,348.37%	-206.35%
Return on Equity Simple (ROE_SIMPLE)	15.08%	18.79%	10.86%	11.90%	-0.80%	-8.37%	-1.01%	-4.58%	127.20%	371.09%
Net Operating Profit after Tax (NOPAT)	240	234	176	229	78	-0.22	27	19	-7.69	-173
NOPAT Margin	4.81%	5.44%	4.46%	6.66%	2.56%	-0.01%	1.38%	1.04%	-0.82%	-17.60%
Net Nonoperating Expense Percent (NNEP)	4.03%	-4.42%	3.73%	11.12%	7.63%	8.79%	6.96%	3.41%	8.17%	31.28%
Return On Investment Capital (ROIC_SIMPLE)	9.56%	9.43%	7.17%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	79.73%	77.19%	78.02%	77.33%	77.50%	77.80%	78.23%	75.60%	74.83%	73.53%
SG&A Expenses to Revenue	12.61%	14.12%	14.35%	15.29%	16.49%	19.89%	17.83%	18.51%	22.29%	21.16%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	13.83%	15.49%	15.89%	17.12%	18.85%	22.22%	19.79%	22.91%	26.34%	51.61%
Earnings before Interest and Taxes (EBIT)	327	404	254	177	99	-7.31	36	-17	3.42	-247
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	395	471	324	251	183	55	80	24	29	-221
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.81	4.20	3.95	4.35	2.88	2.90	0.76	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.79	1.39	1.39	1.49	0.96	1.14	0.24	0.20	0.13	0.12
Price to Earnings (P/E)	18.99	22.87	31.79	36.57	0.00	0.00	0.00	95.69	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	5.27%	4.37%	3.15%	2.73%	0.00%	0.00%	0.00%	1.05%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.21	3.12	2.90	3.45	1.93	1.81	0.87	2.02	1.31	1.50
Enterprise Value to Revenue (EV/Rev)	0.93	1.55	1.58	1.76	1.30	1.67	0.49	0.49	0.68	0.60
Enterprise Value to EBITDA (EV/EBITDA)	11.77	14.19	19.26	24.13	21.61	69.91	11.97	36.80	21.60	0.00
Enterprise Value to EBIT (EV/EBIT)	14.23	16.53	24.54	34.16	39.77	0.00	26.64	0.00	186.46	0.00
Enterprise Value to NOPAT (EV/NOPAT)	19.33	28.55	35.52	26.45	50.90	0.00	35.84	46.57	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	14.37	18.01	23.34	29.07	30.98	97.61	39.30	23.48	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	16.71	26.76	0.00	11.80	24.21	0.00	0.00	13.41	0.00	10.35
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.79	0.75	0.77	0.91	1.11	1.42	0.89	-179.79	11.77	-23.28
Long-Term Debt to Equity	0.79	0.74	0.76	0.90	1.10	1.41	0.89	-179.15	11.29	-21.92
Financial Leverage	0.50	0.53	0.53	0.73	1.17	1.14	1.58	24.98	42.04	4.09
Leverage Ratio	2.35	2.25	2.30	2.48	2.72	2.66	3.38	33.83	55.61	6.82
Compound Leverage Factor	2.04	2.00	1.86	1.63	-0.14	28.47	-0.82	29.45	-556.22	9.01
Debt to Total Capital	44.17%	42.77%	43.43%	47.55%	52.54%	58.66%	47.22%	100.56%	92.17%	104.49%
Short-Term Debt to Total Capital	0.26%	0.24%	0.24%	0.27%	0.43%	0.42%	0.36%	0.36%	3.78%	6.09%
Long-Term Debt to Total Capital	43.92%	42.53%	43.19%	47.28%	52.11%	58.23%	46.86%	100.20%	88.39%	98.40%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	17.17%	14.68%	15.72%
Common Equity to Total Capital	55.83%	57.23%	56.57%	52.45%	47.46%	41.34%	52.78%	-17.73%	-6.86%	-20.21%
Debt to EBITDA	2.81	2.26	3.28	4.24	6.16	23.35	6.73	19.89	15.33	-1.89
Net Debt to EBITDA	1.77	1.53	2.38	3.77	5.61	22.13	6.27	18.05	15.00	-1.82
Long-Term Debt to EBITDA	2.80	2.24	3.26	4.22	6.11	23.18	6.67	19.82	14.70	-1.78
Debt to NOPAT	4.62	4.54	6.05	4.65	14.50	-5,761.29	20.13	25.17	-58.75	-2.42
Net Debt to NOPAT	2.91	3.07	4.38	4.13	13.22	-5,460.99	18.78	22.84	-57.51	-2.33
Long-Term Debt to NOPAT	4.60	4.51	6.02	4.62	14.38	-5,719.87	19.98	25.08	-56.34	-2.28
Altman Z-Score	3.41	4.12	3.69	3.47	2.39	1.88	1.95	1.82	0.29	-1.07
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	13.68%	431.50%	660.69%	31.64%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.70	1.77	1.76	1.55	1.51	1.69	1.95	1.77	1.33	1.20
Quick Ratio	1.05	1.17	1.19	1.00	0.99	1.19	1.44	1.19	0.91	0.74
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	278	250	-224	514	163	-1,021	-639	66	-104	57
Operating Cash Flow to CapEx	908.25%	973.94%	1,293.25%	813.71%	474.02%	139.55%	92.97%	154.75%	-747.25%	-532.76%
Free Cash Flow to Firm to Interest Expense	5.67	4.88	-4.16	7.67	1.51	-13.84	-13.94	0.00	0.00	0.71
Operating Cash Flow to Interest Expense	6.60	7.25	4.97	3.11	1.18	0.54	0.53	0.00	0.00	-0.81
Operating Cash Flow Less CapEx to Interest Expense	5.87	6.50	4.59	2.73	0.93	0.15	-0.04	0.00	0.00	-0.96
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.51	1.36	1.34	1.26	1.16	1.15	1.91	3.03	1.65	1.45
Accounts Receivable Turnover	12.70	11.39	11.02	10.32	9.29	7.28	9.80	18.79	9.06	8.58
Inventory Turnover	12.04	13.33	15.11	15.56	17.13	18.04	25.00	37.25	17.69	18.01
Fixed Asset Turnover	40.31	37.58	35.88	29.56	23.85	20.42	32.30	61.29	28.96	28.02
Accounts Payable Turnover	7.68	8.25	9.35	9.46	9.33	8.79	11.96	21.20	10.81	9.36
Days Sales Outstanding (DSO)	28.75	32.03	33.12	35.38	39.28	50.13	37.23	19.43	40.27	42.55
Days Inventory Outstanding (DIO)	30.32	27.38	24.16	23.45	21.31	20.23	14.60	9.80	20.63	20.26
Days Payable Outstanding (DPO)	47.50	44.25	39.02	38.58	39.13	41.52	30.53	17.22	33.76	38.98
Cash Conversion Cycle (CCC)	11.57	15.17	18.25	20.25	21.46	28.83	21.30	12.01	27.14	23.83
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,103	2,140	2,156	1,756	2,041	2,126	1,106	440	487	391
Invested Capital Turnover	2.36	2.00	2.02	1.81	1.46	1.43	2.51	3.94	2.13	1.94
Increase / (Decrease) in Invested Capital	-38	-16	400	-284	-85	1,020	666	-47	96	-229
Enterprise Value (EV)	4,647	6,686	6,243	6,062	3,946	3,852	960	889	637	586
Market Capitalization	3,948	5,968	5,473	5,116	2,921	2,633	457	371	122	120
Book Value per Share	$8.25	$8.03	$7.62	$6.54	$5.44	$1.28	$4.71	($0.66)	($0.29)	($1.18)
Tangible Book Value per Share	($2.57)	($0.78)	($0.93)	($1.68)	($2.34)	($1.28)	($1.95)	($3.69)	($3.66)	($5.74)
Total Capital	2,515	2,484	2,450	2,242	2,140	2,193	1,142	478	490	400
Total Debt	1,111	1,063	1,064	1,066	1,124	1,286	539	481	452	418
Total Long-Term Debt	1,105	1,057	1,058	1,060	1,115	1,277	535	479	433	394
Net Debt	699	719	770	946	1,025	1,219	503	436	442	403
Capital Expenditures (CapEx)	36	38	21	26	27	28	26	24	5.69	12
Debt-free, Cash-free Net Working Capital (DFCFNWC)	136	138	141	137	133	171	195	39	52	40
Debt-free Net Working Capital (DFNWC)	549	482	435	257	232	238	232	83	62	55
Net Working Capital (NWC)	542	476	429	251	223	229	227	81	43	31
Net Nonoperating Expense (NNE)	29	-33	25	89	86	76	33	15	35	127
Net Nonoperating Obligations (NNO)	699	719	770	580	1,025	1,219	503	443	449	409
Total Depreciation and Amortization (D&A)	68	67	70	74	83	62	44	41	26	26
Debt-free, Cash-free Net Working Capital to Revenue	2.73%	3.21%	3.57%	3.99%	4.38%	7.39%	10.06%	2.12%	5.57%	4.04%
Debt-free Net Working Capital to Revenue	10.98%	11.20%	11.03%	7.46%	7.66%	10.30%	11.94%	4.55%	6.59%	5.63%
Net Working Capital to Revenue	10.85%	11.06%	10.88%	7.29%	7.35%	9.90%	11.72%	4.46%	4.62%	3.15%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.23	$1.49	$0.83	$0.78	($0.04)	($0.49)	($1.96)	($2.40)	($2.16)	($18.04)
Adjusted Weighted Average Basic Shares Outstanding	171.57M	178.97M	181.11M	179.86M	179.81M	176.70M	32.04M	31.92M	30.25M	17.19M
Adjusted Diluted Earnings per Share	$1.23	$1.48	$0.83	$0.77	($0.04)	($0.49)	($1.96)	($2.40)	($2.16)	($18.04)
Adjusted Weighted Average Diluted Shares Outstanding	172.85M	180.38M	182.08M	181.21M	179.81M	176.70M	32.04M	31.92M	30.25M	17.19M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	($0.04)	($0.49)	($1.96)	($2.40)	($2.16)	($18.04)
Adjusted Weighted Average Basic & Diluted Shares Outstanding	165.32M	173.50M	181.96M	179.94M	180.97M	156.28M	31.99M	30.95M	23.44M	17.18M
Normalized Net Operating Profit after Tax (NOPAT)	240	234	176	134	78	-0.22	27	19	3.41	21
Normalized NOPAT Margin	4.81%	5.44%	4.46%	3.88%	2.56%	-0.01%	1.38%	1.04%	0.36%	2.09%
Pre Tax Income Margin	5.67%	8.34%	5.22%	3.39%	-0.17%	-3.38%	-0.45%	-0.80%	-3.65%	-33.23%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	6.66	7.89	4.73	2.65	0.92	-0.10	0.79	0.00	0.00	-3.11
NOPAT to Interest Expense	4.90	4.57	3.27	3.42	0.72	0.00	0.58	0.00	0.00	-2.18
EBIT Less CapEx to Interest Expense	5.94	7.15	4.34	2.27	0.67	-0.48	0.21	0.00	0.00	-3.26
NOPAT Less CapEx to Interest Expense	4.18	3.83	2.88	3.04	0.47	-0.39	0.01	0.00	0.00	-2.33
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	119.31%	93.70%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Option Care Health's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	16.31%	19.75%	16.97%	14.79%	12.82%	9.46%	7.06%	9.00%	10.93%	10.79%	14.46%
EBITDA Growth	8.32%	1.56%	3.65%	-45.70%	3.06%	12.08%	18.47%	137.66%	19.72%	23.88%	15.23%
EBIT Growth	8.73%	-0.05%	4.85%	-50.25%	3.61%	14.54%	24.75%	183.19%	27.52%	31.32%	22.16%
NOPAT Growth	7.28%	5.42%	-4.31%	-1.98%	12.70%	22.44%	43.85%	44.02%	25.68%	-48.76%	-6.96%
Net Income Growth	4.36%	5.17%	-4.34%	-53.64%	14.24%	20.30%	45.02%	237.18%	29.51%	-37.02%	9.43%
EPS Growth	7.69%	9.09%	0.00%	-52.38%	23.81%	26.92%	47.62%	231.58%	23.53%	-38.10%	5.00%
Operating Cash Flow Growth	89.51%	-29.13%	162.79%	15.41%	-176.64%	17.29%	-29.95%	62.59%	174.63%	-33.46%	70.11%
Free Cash Flow Firm Growth	108.76%	32.92%	30.66%	-90.49%	-206.49%	121.99%	226.65%	248.09%	796.25%	-191.53%	-256.35%
Invested Capital Growth	0.80%	-1.76%	-2.92%	2.34%	29.05%	-0.73%	-1.39%	-2.25%	-17.79%	22.76%	5.93%
Revenue Q/Q Growth	-1.00%	5.31%	4.19%	7.08%	1.93%	2.87%	2.24%	5.24%	-1.11%	0.62%	4.09%
EBITDA Q/Q Growth	-14.69%	7.56%	0.98%	16.90%	-20.01%	9.76%	-47.09%	121.84%	-13.00%	16.01%	6.14%
EBIT Q/Q Growth	-16.50%	6.36%	1.52%	20.58%	-23.24%	11.58%	-51.82%	151.11%	-15.15%	21.54%	9.36%
NOPAT Q/Q Growth	-9.81%	3.65%	4.89%	9.42%	-11.38%	-5.92%	7.44%	25.80%	-3.72%	10.54%	7.57%
Net Income Q/Q Growth	-22.27%	11.66%	1.53%	18.42%	-21.66%	1.55%	-50.79%	191.78%	-17.51%	22.42%	14.42%
EPS Q/Q Growth	-22.22%	16.13%	3.33%	15.38%	-21.21%	6.45%	-50.79%	200.00%	-19.23%	23.81%	10.53%
Operating Cash Flow Q/Q Growth	-119.97%	-77.48%	-18.02%	384.45%	-234.95%	-16.50%	-64.00%	88.89%	106.54%	-50.13%	-16.43%
Free Cash Flow Firm Q/Q Growth	-60.85%	-17.62%	1,097.54%	102.27%	-694.35%	-19.02%	-12.83%	-74.62%	222.73%	-366.39%	-1.93%
Invested Capital Q/Q Growth	8.91%	2.34%	-4.28%	-5.51%	6.14%	1.13%	0.91%	19.14%	-18.35%	0.45%	0.02%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	19.73%	19.93%	20.08%	20.32%	20.81%	21.98%	23.26%	23.46%	22.54%	22.50%	21.35%
EBITDA Margin	6.95%	8.06%	7.89%	8.14%	7.46%	9.50%	8.91%	17.21%	8.16%	9.28%	8.05%
Operating Margin	5.94%	6.46%	6.66%	6.57%	6.02%	7.52%	7.42%	7.70%	6.56%	6.64%	5.95%
EBIT Margin	5.63%	6.68%	6.61%	6.78%	6.02%	8.00%	7.37%	15.65%	6.56%	7.64%	6.33%
Profit (Net Income) Margin	3.51%	4.47%	4.21%	4.32%	3.91%	5.09%	5.15%	10.70%	3.86%	4.63%	3.80%
Tax Burden Percent	73.54%	74.19%	73.22%	73.63%	78.64%	72.44%	80.33%	73.57%	72.30%	73.37%	74.54%
Interest Burden Percent	84.68%	90.17%	87.04%	86.55%	82.51%	87.76%	86.96%	92.95%	81.39%	82.50%	80.61%
Effective Tax Rate	26.46%	25.81%	26.78%	26.37%	21.36%	27.56%	19.67%	26.43%	27.70%	26.63%	25.46%
Return on Invested Capital (ROIC)	9.93%	11.30%	11.16%	10.47%	10.41%	10.91%	11.75%	11.04%	9.83%	9.82%	8.17%
ROIC Less NNEP Spread (ROIC-NNEP)	8.64%	10.67%	9.86%	9.53%	8.90%	10.36%	10.57%	18.30%	8.48%	9.45%	7.43%
Return on Net Nonoperating Assets (RNNOA)	5.54%	5.35%	4.49%	4.48%	4.01%	5.49%	5.65%	9.83%	4.39%	4.98%	5.30%
Return on Equity (ROE)	15.47%	16.65%	15.65%	14.95%	14.43%	16.41%	17.40%	20.87%	14.22%	14.80%	13.47%
Cash Return on Invested Capital (CROIC)	9.92%	13.10%	14.32%	8.98%	-13.50%	11.63%	11.85%	11.90%	29.05%	-11.45%	4.83%
Operating Return on Assets (OROA)	8.90%	10.05%	9.46%	9.34%	8.37%	10.87%	9.82%	20.51%	8.83%	10.21%	8.30%
Return on Assets (ROA)	5.55%	6.72%	6.03%	5.95%	5.43%	6.91%	6.86%	14.03%	5.20%	6.18%	4.99%
Return on Common Equity (ROCE)	15.47%	16.65%	15.65%	14.95%	14.43%	16.41%	17.40%	20.87%	14.22%	14.80%	13.47%
Return on Equity Simple (ROE_SIMPLE)	15.83%	0.00%	14.64%	14.97%	19.08%	0.00%	17.88%	16.26%	11.81%	0.00%	13.35%
Net Operating Profit after Tax (NOPAT)	58	65	62	59	54	61	65	61	48	50	45
NOPAT Margin	4.37%	4.80%	4.87%	4.84%	4.74%	5.45%	5.96%	5.67%	4.74%	4.87%	4.43%
Net Nonoperating Expense Percent (NNEP)	1.29%	0.63%	1.29%	0.94%	1.52%	0.55%	1.19%	-7.26%	1.35%	0.37%	0.74%
Return On Investment Capital (ROIC_SIMPLE)	2.37%	2.57%	-	-	-	2.47%	-	-	-	2.04%	-
Cost of Revenue to Revenue	80.27%	80.07%	79.92%	79.68%	79.19%	78.02%	76.74%	76.54%	77.46%	77.50%	78.65%
SG&A Expenses to Revenue	12.61%	12.23%	12.28%	12.53%	13.50%	13.14%	14.48%	14.36%	14.56%	14.44%	13.91%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	13.79%	13.47%	13.43%	13.75%	14.79%	14.46%	15.85%	15.76%	15.98%	15.86%	15.41%
Earnings before Interest and Taxes (EBIT)	75	90	85	83	69	90	81	167	67	79	65
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	93	109	101	100	85	107	97	184	83	95	82
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.28	2.81	3.75	3.41	4.16	4.20	4.04	3.96	4.28	3.95	4.28
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.11	0.79	1.12	1.05	1.34	1.39	1.38	1.41	1.43	1.39	1.49
Price to Earnings (P/E)	28.06	18.99	26.41	22.78	21.79	22.87	23.89	24.82	36.25	31.79	29.75
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	3.56%	5.27%	3.79%	4.39%	4.59%	4.37%	4.19%	4.03%	2.76%	3.15%	3.36%
Enterprise Value to Invested Capital (EV/IC)	2.93	2.21	2.91	2.59	2.99	3.12	3.07	3.08	3.72	2.90	3.04
Enterprise Value to Revenue (EV/Rev)	1.30	0.93	1.25	1.21	1.53	1.55	1.54	1.56	1.62	1.58	1.70
Enterprise Value to EBITDA (EV/EBITDA)	16.71	11.77	15.22	14.25	14.32	14.19	14.13	14.54	19.38	19.26	21.36
Enterprise Value to EBIT (EV/EBIT)	20.19	14.23	18.31	17.19	16.67	16.53	16.53	17.14	24.35	24.54	27.71
Enterprise Value to NOPAT (EV/NOPAT)	27.47	19.33	25.24	23.16	28.37	28.55	29.15	31.65	35.26	35.52	29.55
Enterprise Value to Operating Cash Flow (EV/OCF)	17.45	14.37	17.68	23.23	31.88	18.01	17.86	16.58	20.17	23.34	22.57
Enterprise Value to Free Cash Flow (EV/FCFF)	29.68	16.71	20.02	29.11	0.00	26.76	25.71	25.59	11.55	0.00	64.78
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.82	0.79	0.78	0.79	0.74	0.75	0.74	0.72	0.79	0.77	0.80
Long-Term Debt to Equity	0.82	0.79	0.77	0.78	0.74	0.74	0.73	0.72	0.78	0.76	0.79
Financial Leverage	0.64	0.50	0.46	0.47	0.45	0.53	0.53	0.54	0.52	0.53	0.71
Leverage Ratio	2.36	2.35	2.33	2.31	2.30	2.25	2.27	2.28	2.34	2.30	2.41
Compound Leverage Factor	2.00	2.12	2.03	2.00	1.89	1.98	1.98	2.12	1.90	1.90	1.94
Debt to Total Capital	45.12%	44.17%	43.80%	44.07%	42.64%	42.77%	42.47%	41.89%	44.07%	43.43%	44.32%
Short-Term Debt to Total Capital	0.26%	0.26%	0.26%	0.26%	0.24%	0.24%	0.24%	0.24%	0.25%	0.24%	0.25%
Long-Term Debt to Total Capital	44.86%	43.92%	43.55%	43.81%	42.40%	42.53%	42.23%	41.65%	43.82%	43.19%	44.07%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	54.88%	55.83%	56.20%	55.93%	57.36%	57.23%	57.53%	58.11%	55.93%	56.57%	55.68%
Debt to EBITDA	2.76	2.81	2.83	2.85	2.24	2.26	2.31	2.39	3.15	3.28	3.48
Net Debt to EBITDA	2.34	1.77	1.60	1.89	1.78	1.53	1.47	1.40	2.27	2.38	2.65
Long-Term Debt to EBITDA	2.75	2.80	2.81	2.84	2.23	2.24	2.30	2.38	3.13	3.26	3.46
Debt to NOPAT	4.54	4.62	4.69	4.64	4.44	4.54	4.77	5.21	5.73	6.05	4.82
Net Debt to NOPAT	3.84	2.91	2.65	3.07	3.52	3.07	3.04	3.05	4.13	4.38	3.66
Long-Term Debt to NOPAT	4.51	4.60	4.66	4.61	4.42	4.51	4.74	5.18	5.70	6.02	4.79
Altman Z-Score	3.86	3.19	3.52	3.37	3.79	3.80	3.67	3.65	3.57	3.50	3.51
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.54	1.70	1.73	1.77	1.77	1.77	1.79	1.79	1.66	1.76	1.62
Quick Ratio	0.91	1.05	1.19	1.22	1.25	1.17	1.23	1.25	1.12	1.19	1.06
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	40	102	124	10	-457	77	95	109	429	-350	-75
Operating Cash Flow to CapEx	-76.98%	349.34%	1,658.90%	2,001.18%	-1,181.86%	256.32%	724.31%	2,175.21%	1,558.19%	238.15%	1,234.95%
Free Cash Flow to Firm to Interest Expense	3.02	9.40	10.05	0.82	-34.62	6.19	8.06	8.26	31.03	-23.63	-5.36
Operating Cash Flow to Interest Expense	-0.55	3.32	12.99	15.52	-5.21	4.10	5.18	12.85	6.49	2.94	6.23
Operating Cash Flow Less CapEx to Interest Expense	-1.25	2.37	12.21	14.75	-5.65	2.50	4.46	12.26	6.07	1.70	5.72
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.58	1.51	1.43	1.38	1.39	1.36	1.33	1.31	1.35	1.34	1.31
Accounts Receivable Turnover	9.87	12.70	11.77	10.62	9.15	11.39	11.26	10.89	10.62	11.02	10.68
Inventory Turnover	13.58	12.04	13.47	13.23	14.00	13.33	13.30	12.95	13.49	15.11	14.07
Fixed Asset Turnover	41.11	40.31	40.84	39.80	39.13	37.58	41.17	38.99	37.69	35.88	37.86
Accounts Payable Turnover	8.18	7.68	7.41	7.18	7.37	8.25	7.72	7.56	7.83	9.35	8.23
Days Sales Outstanding (DSO)	36.97	28.75	31.02	34.38	39.89	32.03	32.43	33.53	34.36	33.12	34.17
Days Inventory Outstanding (DIO)	26.88	30.32	27.10	27.58	26.07	27.38	27.45	28.18	27.05	24.16	25.93
Days Payable Outstanding (DPO)	44.64	47.50	49.26	50.84	49.56	44.25	47.27	48.31	46.64	39.02	44.35
Cash Conversion Cycle (CCC)	19.21	11.57	8.86	11.12	16.40	15.17	12.60	13.39	14.76	18.25	15.75
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,290	2,103	2,055	2,147	2,272	2,140	2,117	2,098	1,761	2,156	2,146
Invested Capital Turnover	2.27	2.36	2.29	2.16	2.20	2.00	1.97	1.95	2.07	2.02	1.84
Increase / (Decrease) in Invested Capital	18	-38	-62	49	511	-16	-30	-48	-381	400	120
Enterprise Value (EV)	6,717	4,647	5,982	5,550	6,784	6,686	6,496	6,463	6,547	6,243	6,532
Market Capitalization	5,778	3,948	5,353	4,815	5,941	5,968	5,819	5,841	5,781	5,473	5,723
Book Value per Share	$8.17	$8.25	$8.34	$8.12	$8.22	$8.03	$8.01	$8.21	$7.42	$7.62	$7.35
Tangible Book Value per Share	($3.58)	($2.57)	($2.48)	($2.57)	($2.52)	($0.78)	($2.47)	($0.48)	($1.01)	($0.93)	($1.20)
Total Capital	2,462	2,515	2,538	2,524	2,491	2,484	2,503	2,539	2,414	2,450	2,402
Total Debt	1,111	1,111	1,112	1,112	1,062	1,063	1,063	1,063	1,064	1,064	1,065
Total Long-Term Debt	1,104	1,105	1,105	1,106	1,056	1,057	1,057	1,057	1,058	1,058	1,059
Net Debt	939	699	629	735	843	719	677	622	766	770	809
Capital Expenditures (CapEx)	9.37	10	9.67	9.78	5.82	20	8.43	7.79	5.76	18	7.06
Debt-free, Cash-free Net Working Capital (DFCFNWC)	221	136	82	162	279	138	112	95	119	141	116
Debt-free Net Working Capital (DFNWC)	392	549	565	539	499	482	498	536	417	435	371
Net Working Capital (NWC)	386	542	558	532	493	476	492	530	411	429	365
Net Nonoperating Expense (NNE)	11	4.44	8.45	6.36	9.50	4.08	8.81	-54	8.96	2.50	6.44
Net Nonoperating Obligations (NNO)	939	699	629	735	843	719	677	622	410	770	809
Total Depreciation and Amortization (D&A)	18	19	16	17	16	17	17	17	16	17	18
Debt-free, Cash-free Net Working Capital to Revenue	4.26%	2.73%	1.71%	3.52%	6.30%	3.21%	2.66%	2.29%	2.95%	3.57%	3.01%
Debt-free Net Working Capital to Revenue	7.56%	10.98%	11.82%	11.73%	11.25%	11.20%	11.85%	12.96%	10.31%	11.03%	9.65%
Net Working Capital to Revenue	7.44%	10.85%	11.69%	11.59%	11.12%	11.06%	11.70%	12.82%	10.16%	10.88%	9.50%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.28	$0.34	$0.32	$0.31	$0.26	$0.32	$0.31	$0.64	$0.22	$0.26	$0.21
Adjusted Weighted Average Basic Shares Outstanding	165.46M	171.57M	170.64M	172.93M	173.93M	178.97M	178.83M	179.81M	181.26M	181.11M	181.88M
Adjusted Diluted Earnings per Share	$0.28	$0.36	$0.31	$0.30	$0.26	$0.33	$0.31	$0.63	$0.21	$0.26	$0.21
Adjusted Weighted Average Diluted Shares Outstanding	166.80M	172.85M	171.94M	174.09M	175.62M	180.38M	180.53M	181.24M	182.74M	182.08M	183.02M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	163.75M	165.32M	170.18M	171.02M	173.82M	173.50M	177.13M	179.88M	179.76M	181.96M	181.90M
Normalized Net Operating Profit after Tax (NOPAT)	58	65	62	59	54	61	65	61	48	50	45
Normalized NOPAT Margin	4.37%	4.80%	4.87%	4.84%	4.74%	5.45%	5.96%	5.67%	4.74%	4.87%	4.43%
Pre Tax Income Margin	4.77%	6.02%	5.75%	5.87%	4.97%	7.02%	6.41%	14.55%	5.34%	6.31%	5.10%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.67	8.26	6.85	6.60	5.23	7.23	6.84	12.68	4.82	5.31	4.62
NOPAT to Interest Expense	4.40	5.94	5.05	4.71	4.11	4.93	5.52	4.59	3.48	3.38	3.23
EBIT Less CapEx to Interest Expense	4.96	7.31	6.06	5.83	4.79	5.63	6.12	12.09	4.40	4.07	4.11
NOPAT Less CapEx to Interest Expense	3.69	4.99	4.26	3.94	3.67	3.33	4.81	4.00	3.07	2.15	2.73
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	119.31%	112.64%	138.84%	78.96%	93.70%	68.02%	31.25%	47.03%	0.00%	0.00%

Frequently Asked Questions About Option Care Health's Financials

When does Option Care Health's fiscal year end?

According to the most recent income statement we have on file, Option Care Health's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Option Care Health's net income changed over the last 9 years?

Option Care Health's net income appears to be on an upward trend, with a most recent value of $211.82 million in 2024, falling from -$300.13 million in 2015. The previous period was $267.09 million in 2023. See Option Care Health's forecast for analyst expectations on what’s next for the company.

What is Option Care Health's operating income?

Option Care Health's total operating income in 2024 was $321.83 million, based on the following breakdown:

Total Gross Profit: $1.01 billion
Total Operating Expenses: $691.16 million

How has Option Care Health revenue changed over the last 9 years?

Over the last 9 years, Option Care Health's total revenue changed from $982.22 million in 2015 to $5.00 billion in 2024, a change of 408.9%.

How much debt does Option Care Health have?

Option Care Health's total liabilities were at $2.02 billion at the end of 2024, a 12.4% increase from 2023, and a 267.8% increase since 2015.

How much cash does Option Care Health have?

In the past 9 years, Option Care Health's cash and equivalents has ranged from $9.57 million in 2016 to $412.57 million in 2024, and is currently $412.57 million as of their latest financial filing in 2024.

How has Option Care Health's book value per share changed over the last 9 years?

Over the last 9 years, Option Care Health's book value per share changed from -1.18 in 2015 to 8.25 in 2024, a change of -801.4%.

Related Companies

This page (NASDAQ:OPCH) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Option Care Health (OPCH) Financials

Frequently Asked Questions About Option Care Health's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Option Care Health (OPCH) Financials

Annual Income Statements for Option Care Health

Quarterly Income Statements for Option Care Health

Annual Cash Flow Statements for Option Care Health

Quarterly Cash Flow Statements for Option Care Health

Annual Balance Sheets for Option Care Health

Quarterly Balance Sheets for Option Care Health

Annual Metrics And Ratios for Option Care Health

Quarterly Metrics And Ratios for Option Care Health

Frequently Asked Questions About Option Care Health's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools